GoodRx Holdings, Inc. GDRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $194.01M-0.4% | $194.79M-0.6% | $196.03M-3.5% | $203.07M0.0% | $202.97M+2.2% | ||
| $20.16M+15.4% | $17.46M+30.1% | $13.42M+0.5% | $13.35M-0.1% | $13.36M+9.6% | ||
| $173.85M-2.0% | $177.32M-2.9% | $182.61M-3.7% | $189.72M+0.1% | $189.61M+1.7% | ||
| 89.6%-1.4pp | 91%-2.1pp | 93.2%-0.3pp | 93.4%0.0pp | 93.4%-0.4pp | ||
| $30.18M+4.3% | $28.94M-6.7% | $31.01M+3.6% | $29.93M-3.9% | $31.14M-1.9% | ||
| $81.05M+3.1% | $78.62M-5.9% | $83.53M-1.6% | $84.87M+0.4% | $84.54M-9.9% | ||
| $26.82M+12.0% | $23.94M-25.2% | $32.01M+12.8% | $28.38M-4.2% | $29.63M+25.8% | ||
| $180M+4.6% | $172.1M-5.1% | $181.41M+2.9% | $176.26M-1.9% | $179.59M-0.5% | ||
| $14.01M-38.2% | $22.68M+55.2% | $14.62M-45.5% | $26.81M+14.7% | $23.38M+28.6% | ||
| 7.2%-4.4pp | 11.6%+4.2pp | 7.5%-5.7pp | 13.2%+1.7pp | 11.5%+2.4pp | ||
| $9.77M-6.1% | $10.4M-3.9% | $10.83M+0.9% | $10.73M+0.8% | $10.64M-6.3% | ||
| -$8.37M+1.4% | -$8.49M+0.4% | -$8.52M-17.8% | -$7.23M-7.7% | -$6.71M+0.9% | ||
| $5.64M-60.3% | $14.19M+133% | $6.1M-68.8% | $19.58M+17.5% | $16.67M+46.1% | ||
| $4.47M-49.0% | $8.77M+76.0% | $4.98M-26.0% | $6.73M+19.9% | $5.62M+20.3% | ||
| $1.17M-78.5% | $5.43M+385% | $1.12M-91.3% | $12.84M+16.2% | $11.05M+64.0% | ||
| 0.6%-2.2pp | 2.8%+2.2pp | 0.6%-5.8pp | 6.3%+0.9pp | 5.4%+2.1pp | ||
| $0.00-100% | $0.02— | $0.00-100% | $0.04+33.3% | $0.03+50.0% | ||
| $35.8M-21.9% | $45.83M+27.1% | $36.05M-22.5% | $46.54M+5.1% | $44.29M+18.8% | ||
| 18.5%-5.1pp | 23.5%+5.1pp | 18.4%-4.5pp | 22.9%+1.1pp | 21.8%+3.1pp | ||
| $14.01M-38.2% | $22.68M+55.2% | $14.62M-45.5% | $26.81M+14.7% | $23.38M+28.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is GoodRx Holdings, Inc.'s revenue?
- GoodRx Holdings, Inc. (GDRX) generated $787.9M in revenue over the trailing twelve months, down 1.2% year over year.
- Is GoodRx Holdings, Inc. profitable?
- GoodRx Holdings, Inc. reported $20.6M in net income over the trailing twelve months, a 2.6% net margin.
- What are GoodRx Holdings, Inc.'s profit margins?
- Gross margin is 91.8% and operating margin is 9.9%, with a 2.6% net margin.
- What is GoodRx Holdings, Inc.'s earnings per share?
- GoodRx Holdings, Inc.'s diluted EPS over the trailing twelve months is $0.06.
- Where does GoodRx Holdings, Inc.'s income statement data come from?
- Every line is extracted from GoodRx Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
